Liraglutide's potential to improve cardiac microvascular function in Type 2 Diabetes investigated.
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Abstract
A randomized crossover study explored whether liraglutide could enhance coronary microvascular perfusion in 20 Type 2 Diabetes patients.